References
- Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:j1.
- Higa R, Jawerbaum A. Intrauterine effects of impaired lipid homeostasis in pregnancy diseases. [review]. Curr Med Chem. 2013;20(18):2338–2350.
- Mandò C, Calabrese S, Mazzocco MI, et al. Sex specific adaptations in placental biometry of overweight and obese women. Placenta. 2016;38:1–7.
- Myatt L, Maloyan A. Obesity and placental function. Semin Reprod Med. 2016;34(1):42–49.
- Berglund SK, García-Valdés L, Torres-Espinola FJ, et al. Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE). BMC Publ Health. 2016;16:207.
- Scifres CM, Parks WT, Feghali M, et al. Placental maternal vascular malperfusion and adverse pregnancy outcomes in gestational diabetes mellitus. Placenta. 2017;49:10–15.
- Taricco E, Radaelli T, Rossi G, et al. Effects of gestational diabetes on fetal oxygen and glucose levels in vivo. BJOG. 2009;116(13):1729–1735.
- Berti C, Cetin I, Agostoni C, et al. Pregnancy and infants’ outcome: nutritional and metabolic implications. Crit Rev Food Sci Nutr. 2016;56(1):82–91.
- Cetin I, Parisi F, Berti C, et al. Placental fatty acid transport in maternal obesity. J Dev Orig Health Dis. 2012;3(6):409–414.
- Mandò C, De Palma C, Stampalija T, et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab. 2014;306(4):E404–E413.
- Colleoni F, Lattuada D, Garretto A, et al. Maternal blood mitochondrial DNA content during normal and intrauterine growth restricted (IUGR) pregnancy. Am J Obstet Gynecol. 2010;203(4):365:e1–e6.
- Mandò C, Novielli C, Anelli GM, et al. Alterations of mitochondrial content in obese placentas. [abstract]. Reprod Sci. 2015;22(Suppl 1):374A.
- Lee HJ, Choi JS, Lee HJ, et al. Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction. J Nutr Biochem. 2015;26(12):1414–1423.
- Koenig MD, Tussing-Humphreys L, Day J, et al. Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014;6(8):3062–3083.
- Rehu M, Punnonen K, Ostland V, et al. Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol. 2010;85(4):345–352.
- Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131(Suppl 3):S173–S211.
- Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51(3):353–361.
- Mandò C, Razini P, Novielli C, et al. Impaired angiogenic potential of human placental mesenchymal stromal cells in intrauterine growth restriction. Stem Cells Transl Med. 2016;5(4):451–463.
- Heazell AE, Moll SJ, Jones CJ, et al. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta. 2007;28(Suppl A):S33–S40.
- Hastie R, Lappas M. The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity. Placenta. 2014;35(9):673–683.
- Borengasser SJ, Lau F, Kang P, et al. Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. PLoS One. 2011;6(8):e24068.
- Dao MC, Sen S, Iyer C, et al. Obesity during pregnancy and fetal iron status: is hepcidin the link? J Perinatol. 2013;33(3):177–181.
- Garcia-Valdes L, Campoy C, Hayes H, et al. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Int J Obes (Lond). 2015;39(4):571–578.
- Parisi F, Berti C, Mandò C, et al. Effects of different regimens of iron prophylaxis on maternal iron status and pregnancy outcome: a randomized control trial. J Matern Fetal Neonatal Med. 2017;30(15):1787–1792.
- Montgomery MK, Turner N. Mitochondrial dysfunction and insulin resistance: an update. Endocr Connect. 2015;4(1):R1–RR15.
- Aregbesola A, Voutilainen S, Virtanen JK, et al. Serum hepcidin concentrations and type 2 diabetes. [review]. World J Diabetes. 2015;6(7):978–982.
- Zheng LD, Linarelli LE, Liu L, et al. Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans. Clin Epigenetics. 2015;7:60.
- Schoenaker DA, Mishra GD, Callaway LK, et al. The role of energy, nutrients, foods, and dietary patterns in the development of gestational diabetes mellitus: a systematic review of observational studies. [review]. Diabetes Care. 2016;39(1):16–23.
- Klinge CM. Estrogens regulate life and death in mitochondria. J Bioenerg Biomembr. 2017[11 April];[1–18]. [Epub ahead of print]. doi: 10.1007/s10863-017-9704-1
- Kim DW, Young SL, Grattan DR, et al. Obesity during pregnancy disrupts placental morphology, cell proliferation, and inflammation in a sex-specific manner across gestation in the mouse. Biol Reprod. 2014;90(6):130.